Almost 60 percent of pacemaker patients had undiagnosed sleep apnea — possibly contributing to their heart disease — researchers reported in a small study in Circulation: Journal of the American Heart Association.
Men are more likely than women to benefit from the use of a clot-busting drug after stroke, according to a study published in the March 13, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.
In response to the FDA’s recent public health advisory citing potential dangers of overusing Erythropoiesis-Stimulating Agents (ESAs), the Renal Physicians Association (RPA) urges caution among its doctors and patients when considering any changes to anemia management regimens.
Advances in radiation therapy for cancer have made it possible to fine-tune radiation beams so they match the shape and position of a patient’s tumor nearly anywhere in the body.
Most postmenopausal women with small breast tumors don?t need chemotherapy to reduce their recurrence risk after lumpectomy.
Scientists have highlighted for the first time the plight of the growing number of older children and adolescents living with undiagnosed HIV and AIDS in Africa.
Human embryonic stem cells (hESCs) hold great promise forbenefiting degenerative diseases, and do so by invoking multiplemechanisms. Such cells can be grown in a manner compatible with clinicaluse (i.e., without animal feeder layers) and even without the need forimmunosuppression.
Among the drugs that will be discussed in Amsterdam over the next three days are bevacizumab, cetuximab, dasatinib, erlotinib, lapatinib, nilotinib, oblimersen sodium, sorafenib, and sunitinib.
Cancer Treatment Centers of America announced today its plans to launch a new cancer vaccine therapy that expands treatment options for thousands of women with advanced stage ovarian cancer. This innovative treatment will be offered by Cancer Treatment Centers of America and developed by AVAX Technologies, Inc. (OTCMarket: AVXT.OB).
It is well known that cancer patients undergoing chemotherapy and radiation therapy often experience nausea and loss of appetite. But until now, few researchers have looked into why this happens and what can be done to ensure that cancer patients maintain a healthy diet during treatment.